Position in GRFS
as of Mar 31, 2026
· filed Apr 28, 2026
Position Value
$92,390
-$237,253 QoQ
Shares Held
11,520
-67.3% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GRFS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Abel Hall, LLC holds $16,989,938 across 13 Drug Manufacturers - General names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
2,675 | $3,208,475 | |
| 2 | JNJ |
Johnson & Johnson
|
9,158 | $2,325,857 | |
| 3 | NVS |
Novartis AG
|
14,598 | $2,287,798 | |
| 4 | ABBV |
AbbVie Inc.
|
7,378 | $1,856,599 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
20,767 | $1,196,594 | |
| 6 | MRK |
Merck & Co., Inc.
|
7,789 | $1,000,886 | |
| 7 | PFE |
Pfizer Inc
|
40,621 | $978,153 | |
| 8 | NVO |
Novo Nordisk A S
|
19,198 | $920,352 |
All Filings in GRFS
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $92,390 | 11,520 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $329,643 | 35,256 | Shares | Sole | 2026-02-17 | |
| No filing history on record for this holder in this stock. | ||||||